Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...

This year's Rose Bowl was so uncompetitive that fans paid more attention to the commercials than the actual game. To be fair, ...

A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...

Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts.

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating ...

A key differentiator for MariTide is its long-acting profile. Unlike currently marketed GLP-1 drugs, such as Eli Lilly’s ...

Social media users can’t stop talking about a new Eli Lilly and Company commercial that some believe promotes obesity, while others argue that it instead encourages positive body image. The ad, titled ...

Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: ...

Explore the transformation of weight-loss drugs with the rise of GLP-1 pills, the impact of telehealth, and consumer-driven healthcare approaches, and how these trends are changing the landscape of ...

Reuters spoke to three-dozen people inside the industry including retailers, drugmakers, telehealth providers and investors to show how the weight-loss sector is shifting to better meet consumers ...

By Danny Barrett, Jr. University of Mississippi Medical Center JACKSON – Drugs initially approved for diabetes are now an ...